Biogen (BIIB) Tops Q1 EPS by 14c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $219.07 +1.66%
EPS Growth %: -57.8%
Financial Fact:
Selling, general and administrative: 462.7M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -57.8%
Financial Fact:
Selling, general and administrative: 462.7M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Indosat Tbk PT (ISAT:IJ) (PTITF) PT Raised to IDR35.10 at JPMorgan
- Super Micro Computer rises on AI server market optimism
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
